ARTICLE SUMMARY:
Cardiology, long the golden goose of medtech innovation, is facing stiffer headwinds than ever before, threatening to slow new product growth. Yet, these clinical and industry experts remain bullish on the sector’s future prospects.
Within the medical device industry, the cardiovascular market has traditionally been both the largest and the most innovative in terms of new product development. Much of that growth, over the last generation, has occurred in interventional cardiology, which has seen the most rapid expansion of any medtech market, driven by a specialty whose clinicians are the most voracious adopters of new technology.
